Sunshine Biopharma (SBFM) Change in Inventory (2018 - 2026)
Sunshine Biopharma's (SBFM) quarterly Change in Inventory came in at -$78399.0 in Q1 2026, down 113.78% YoY from $568834.0 in Q1 2025, and up 89.86% on a QoQ basis from -$772796.0 in Q4 2025.
Sunshine Biopharma (SBFM) Change in Inventory (2018 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 9 years of Change in Inventory data on file, last reported at -$78399.0 in Q1 2026.
- Quarterly Change in Inventory fell 113.78% year-over-year to -$78399.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $990044.0 (down 77.88% YoY) and the FY2025 annual result came in at $1.6 million, down 72.74% from the prior year.
- Change in Inventory rose to -$78399.0 in Q1 2026, from -$772796.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $2.1 million in Q1 2024 to a low of -$772796.0 in Q4 2025.
- A 5-year average of $581665.2 and a median of $467925.0 in 2023 frame the typical range for Change in Inventory.
- The widest YoY moves for Change in Inventory: up 2456.77% in 2022, down 702.72% in 2022.
- Tracing SBFM's Change in Inventory over 5 years: stood at -$206974.0 in 2022, then jumped by 652.94% to $1.1 million in 2023, then soared by 57.71% to $1.8 million in 2024, then sank by 142.82% to -$772796.0 in 2025, then jumped by 89.86% to -$78399.0 in 2026.
- The last three Change in Inventory figures came in at -$78399.0 (Q1 2026), -$772796.0 (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn | -793,996.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -793,996.00 |
| Jun 30, 2026 | -793,996.00 |
| Mar 31, 2026 | -78,399.00 |
| Mar 31, 2026 | -78,399.00 |
| Dec 31, 2025 | -772,796.00 |
| Dec 31, 2025 | -772,796.00 |
| Sep 30, 2025 | 1.29 Mn |
| Sep 30, 2025 | 1.29 Mn |
| Jun 30, 2025 | 555,075.00 |
| Jun 30, 2025 | 555,075.00 |
| Mar 31, 2025 | 568,834.00 |
| Mar 31, 2025 | 568,834.00 |
| Dec 31, 2024 | 1.80 Mn |
| Dec 31, 2024 | 1.80 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 848,847.00 |
| Jun 30, 2024 | 848,847.00 |
| Mar 31, 2024 | 2.10 Mn |
| Mar 31, 2024 | 2.10 Mn |